Merck Joins Accumulus Synergy as a Sponsor to Transform the

A dozen global pharmaceutical companies have joined effort to accelerate critical therapies to citizens of the worldBURLINGAME, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Accumulus Synergy, a non-profit

Related Keywords

United States , Canada , Kostenloser Wertpapierhandel , Frank Nogueira , Darrel Hicks , Jeremy Chadwick , Amgen , Accumulus Synergy Inc , Head Of Global Development Office , Takeda Pharmaceuticals , Pfizer , Astrazeneca , Bristol Myers Squibb , Johnson , Global Regulatory Affairs Innovation , Accumulus Synergy , Vice President , Strategic Operations , Board Member , Accumulus Synergy Chairman , Senior Vice President , Global Development Office , Merck , Coins , Accumulus , Synergy , Sponsor , Ransform , Lobal , Drug , Egulatory , Submission , Process ,